Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Study of Hyperthermia Combined With Autologous Adoptive Cellular Immunotherapy in the Treatment of Abdominal and Pelvic Malignancies or Metastases

NCT03757858 is registered in ClinicalTrials.gov with Capital Medical University as lead sponsor.

NCT NCT03757858
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03757858 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Study of Hyperthermia Combined With Autologous Adoptive Cellular Immunotherapy in the Treatment of Abdominal and Pelvic Malignancies or Metastases
Lead sponsor
Capital Medical University
Phase
Phase 1/2
Overall status
Completed
Start date
March 1, 2018
Completion date
June 1, 2023
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

abdominal cancer, cancer, liver metastases, metastatic cancer, pelvic cancer, peritoneal metastases